3′-deoxy-3′-18F-fluorothymidine PET imaging of lymphoid tissues in patients with advanced non-small cell lung cancer undergoing anti-programmed cell death-1 therapy

3′-deoxy-3′-18F-fluorothymidine PET imaging of lymphoid tissues in patients with advanced non-small cell lung cancer undergoing anti-programmed cell death-1 therapy

Abstract Background Anti-programmed cell death-1 (anti-PD-1) therapy has become the standard immunotherapy for patients with advanced non-small cell lung cancer (NSCLC). However, little is known about the organs influenced by PD-1 inhibitors on a patient’s tumor immunity. We examined the changes in...

Full description

Saved in:
Bibliographic Details
Main Authors: Masayuki Sato, Yukihiro Umeda, Tetsuya Tsujikawa, Tetsuya Mori, Akikazu Shimada, Tomoaki Sonoda, Makiko Yamaguchi, Chisato Honjo, Yuko Waseda, Yasushi Kiyono, Tamotsu Ishizuka, Hidehiko Okazawa
Format: Article
Language:English
Published: SpringerOpen 2025-04-01
Series:EJNMMI Research
Subjects:
18F-FLT PET
PD-1 inhibitor
Lung cancer
Spleen
Bone marrow
Proliferation
Online Access:https://doi.org/10.1186/s13550-025-01225-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items